The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy
Open accessAbstract
Heat shock proteins (HSPs) constitute a large family of molecular chaperones classified by their molecular weights, and they include HSP27, HSP40, HSP60, HSP70, and HSP90. HSPs function in diverse physiological and protective processes to assist in maintaining cellular homeostasis. In particular, HSPs participate in protein folding and maturation processes under diverse stressors such as heat shock, hypoxia, and degradation. Notably, HSPs also play essential roles across cancers as they are implicated in a variety of cancer-related activities such as cell proliferation, metastasis, and anti-cancer drug resistance. In this review, we comprehensively discuss the functions of HSPs in association with cancer initiation, progression, and metastasis and anti-cancer therapy resistance. Moreover, the potential utilization of HSPs to enhance the effects of chemo-, radio-, and immunotherapy is explored. Taken together, HSPs have multiple clinical usages as biomarkers for cancer diagnosis and prognosis as well as the potential therapeutic targets for anti-cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Cordonnier, T., Bishop, J. L., Shiota, M., Nip, K. M., Thaper, D., Vahid, S., Heroux, D., Gleave, M. E., & Zoubeidi, A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29122 · Cited by 71
RetractedFu, W., Wang, W.-M., Wang, H., Zhu, X. M., Liang, Y. Q., Kung, H., & Zhang, J. (2013) · Cell Biology International · doi:10.1002/cbin.10193 · Cited by 12
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,228
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,563
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
Guidelines for the nomenclature of the human heat shock proteins
Kampinga, H. H., Hageman, J., Vos, M. J., Kubota, H., Tanguay, R. M., Bruford, E. A., Cheetham, M. E., Chen, B., & Hightower, L. E. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0068-7 · Cited by 1,360
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
Heat shock proteins in cancer: chaperones of tumorigenesis
Calderwood, S. K., Khaleque, M. A., Sawyer, D. B., & Ciocca, D. R. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.01.006 · Cited by 957
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., Zhou, A., Eyob, H., Balakrishnan, S., Wang, C.-Y., et al. (2015) · Nature · doi:10.1038/nature15260 · Cited by 893
Heat Shock Proteins and Cancer
Wu, J., Liu, T., Rios, Z., Mei, Q., Lin, X., & Cao, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.11.009 · Cited by 696
Zhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., Zhang, B., Wang, M., Mao, F., Yan, Y., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt194 · Cited by 644
Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González‐Gallego, J. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 626
Davis, M. E., Motion, J. P. M., Narmoneva, D. A., Takahashi, T., Hakuno, D., Kamm, R. D., Zhang, S., & Lee, R. T. (2005) · Circulation · doi:10.1161/01.cir.0000153847.47301.80 · Cited by 575
Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.040 · Cited by 545
Pharmacologic resistance in colorectal cancer: a review
Hammond, W. A., Swaika, A., & Mody, K. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015614530 · Cited by 519
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis
Fernández, A., Ordóñez, R., Reiter, R. J., González‐Gallego, J., & Mauriz, J. L. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12264 · Cited by 515
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Murphy, M. E. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt111 · Cited by 502
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Chatterjee, S., & Burns, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091978 · Cited by 501
Targeting heat shock proteins in cancer
Jego, G., Hazoumé, A., Seigneuric, R., & Garrido, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.10.014 · Cited by 452
Heat Shock Proteins Promote Cancer: It's a Protection Racket
Calderwood, S. K., & Gong, J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.003 · Cited by 407
Heat Shock Proteins as Immunomodulants
Zininga, T., Ramatsui, L., & Shonhai, A. (2018) · Molecules · doi:10.3390/molecules23112846 · Cited by 380
HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
Xiao, X., Wang, W., Li, Y., Yang, D., Li, X., Shen, C., Liu, Y., Ke, X., Guo, S., & Guo, Z. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0880-6 · Cited by 311
Dual Role of Heat Shock Proteins as Regulators of Apoptosis and Innate Immunity
Joly, A.-L., Wettstein, G., Mignot, G., Ghiringhelli, F., & Garrido, C. (2010) · Journal of Innate Immunity · doi:10.1159/000296508 · Cited by 301
Zou, X., Zhang, G., Cheng, Z., Yin, D., Du, T., Ju, G., Miao, S., Liu, G., Lu, M., & Zhu, Y. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt428 · Cited by 269
Rethinking HSF1 in Stress, Development, and Organismal Health
Li, J., Labbadia, J., & Morimoto, R. I. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.08.002 · Cited by 267
Noordhuis, P., Holwerda, U., Van der Wilt, C. L., Van Groeningen, C. J., Smid, K., Meijer, S., Pinedo, H. M., & Peters, G. J. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh264 · Cited by 264
A J-Protein Co-chaperone Recruits BiP to Monomerize IRE1 and Repress the Unfolded Protein Response
Amin-Wetzel, N., Saunders, R. A., Kamphuis, M. J., Rato, C., Preissler, S., Harding, H. P., & Ron, D. (2017) · Cell · doi:10.1016/j.cell.2017.10.040 · Cited by 252
AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs
Collino, F., Bruno, S., Incarnato, D., Dettori, D., Neri, F., Provero, P., Pomatto, M., Oliviero, S., Tetta, C., Quesenberry, P. J., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070710 · Cited by 249
Camilleri, E. T., Gustafson, M. P., Dudakovic, A., Riester, S. M., Garces, C. G., Paradise, C. R., Takai, H., Karperien, M., Cool, S., Sampen, H.-J. I., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0370-8 · Cited by 240
Jensen, M. R., Schoepfer, J., Radimerski, T., Massey, A., Guy, C. T., Brueggen, J., Quadt, C., Buckler, A., Cozens, R., Drysdale, M. J., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr1996 · Cited by 229
Yokota, S., Kitahara, M., & Nagata, K. (2000) · PubMed · Cited by 228
Drug-Induced Renal Failure: Update on New Medications and Unique Mechanisms of Nephrotoxicity
Perazella, M. A. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200306000-00006 · Cited by 225
Hsp70 in cancer: back to the future
Sherman, M. Y., & Gabai, V. L. (2015) · Oncogene · doi:10.1038/onc.2014.349 · Cited by 211
Mias, C., Trouche, E., Seguelas, M.-H., Calcagno, F., Dignat-George, F., Sabatier, F., Piercecchi-Marti, M.-D., Daniel, L., Bianchi, P., Calise, D., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1000 · Cited by 203
Shiota, M., Bishop, J. L., Nip, K. M., Zardan, A., Takeuchi, A., Cordonnier, T., Beraldi, E., Bazov, J., Fazli, L., Chi, K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3979 · Cited by 194
Current concepts in clinical radiation oncology
Orth, M., Lauber, K., Niyazi, M., Friedl, A. A., Li, M., Maihöfer, C., Schüttrumpf, L., Ernst, A., Niemöller, O. M., & Belka, C. (2014) · Radiation and Environmental Biophysics · doi:10.1007/s00411-013-0497-2 · Cited by 178
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
Mbofung, R. M., McKenzie, J. A., Malu, S., Zhang, M., Peng, W., Liu, C., Kuiatse, I., Tieu, T., Williams, L., Devi, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00449-z · Cited by 159
Wang, B., Jia, H., Zhang, B., Wang, J., Ji, C., Zhu, X., Yan, Y., Yin, L., Yu, J., Qian, H., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0463-4 · Cited by 159
Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer
Saini, J., & Sharma, P. K. (2017) · Current Drug Targets · doi:10.2174/1389450118666170823121248 · Cited by 155
Desai, S., Liu, Z., Yao, J., Patel, N., Chen, J., Wu, Y., Ahn, E.-Y. E., Fodstad, Ø., & Tan, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422071 · Cited by 151
Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27
Hsu, H., Lin, J.-H., Huang, W., Hsu, T., Su, K., Chiou, S., Tsai, Y.-T., & Hung, S. (2010) · Cancer · doi:10.1002/cncr.25599 · Cited by 145
de La Motte Rouge, T., Galluzzi, L., Olaussen, K. A., Zermati, Y., Tasdemir, E., Robert, T., Ripoche, H., Lazar, V., Dessen, P., Harper, F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0538 · Cited by 141
Ledford, H. K. (2011) · Nature · doi:10.1038/472273a · Cited by 135
Heat Shock Protein 70 Promotes Cancer Cell Viability by Safeguarding Lysosomal Integrity
Gyrd‐Hansen, M., Nylandsted, J., & Jäättelä, M. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1287 · Cited by 134
Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
Choi, S.-K., Kam, H., Kim, K.-Y., Park, S. I., & Lee, Y. (2019) · Cancers · doi:10.3390/cancers11081195 · Cited by 130
Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
Wiech, M., Olszewski, M. B., Tracz-Gaszewska, Z., Wawrzynow, B., Zylicz, M., & Zylicz, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051426 · Cited by 129
IGF-1 C Domain–Modified Hydrogel Enhances Cell Therapy for AKI
Feng, G., Zhang, J., Yang, L., Nie, Y., Zhu, D., Wang, R., Liu, J., Gao, J., Liu, N., He, N., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050578 · Cited by 126
ATP and ADP Modulate a Cation Channel Formed by Hsc70 in Acidic Phospholipid Membranes
Arispe, N. J., & Maio, A. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005226200 · Cited by 122
HSF1 as a Cancer Biomarker and Therapeutic Target
Carpenter, R. L., & Gökmen‐Polar, Y. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666181018162117 · Cited by 122
The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation
Multhoff, G., Pockley, A. G., Schmid, T. E., & Schilling, D. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.013 · Cited by 117
Wang, N., Wang, Z., Peng, C. Y., You, J., Shen, J., Han, S., & Chen, J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu187 · Cited by 116
Shahrbaf, F. G., & Assadi, F. K. (2015) · PubMed Central · doi:10.12861/jrip.2015.12 · Cited by 116
Chen, S.-F., Nieh, S., Jao, S., Liu, C., Wu, C.-H., Chang, Y., Yang, C., & Lin, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049275 · Cited by 113
Specht, H. M., Ahrens, N., Blankenstein, C., Duell, T., Fietkau, R., Gaipl, U. S., Günther, C., Günther, S., Habl, G., Hautmann, H., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00162 · Cited by 108
Tang, H., Li, J., Liu, X., Wang, G., Luo, M., & Deng, H. (2016) · Scientific Reports · doi:10.1038/srep28388 · Cited by 108
Heinrich, J. C., Tuukkanen, A. T., Schroeder, M., Fahrig, T., & Fahrig, R. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1005-1 · Cited by 106
Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment
Patel, H., Modi, S., Chiosis, G., & Taldone, T. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.563296 · Cited by 103
Nagaraju, G. P., Long, T., Park, W., Landry, J. C., Taliaferro-Smith, L. D., Farris, A. B., Diaz, R., & El‐Rayes, B. F. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22185 · Cited by 102
Endo, H., Yano, M., Okumura, Y., & Kido, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.550 · Cited by 95
Bone Marrow Vascular Niche: Home for Hematopoietic Stem Cells
He, N., Zhang, L., Cui, J., & Li, Z. (2014) · Bone Marrow Research · doi:10.1155/2014/128436 · Cited by 95
Giulino-Roth, L. G., van Besien, H. J., Dalton, T. C., Totonchy, J. E., Rodina, A., Taldone, T., Bolaender, A., Erdjument‐Bromage, H., Sadek, J., Chadburn, A., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0848 · Cited by 95
Shridhar, V., Bible, K. C., Staub, J. K., et al. (2001) · PubMed · Cited by 92
Chen, K., Qian, W., Li, J., Jiang, Z., Cheng, L., Yan, B., Cao, J., Sun, L., Zhou, C., Lei, M., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12116 · Cited by 92
Kim, J. A., Lee, S., Kim, D., Kim, M., Kwon, B., & Han, D. C. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv045 · Cited by 91
Self-citationLi, J., Song, P., Jiang, T., Dai, D., Wang, H., Sun, J., Zhu, L., Xu, W., Feng, L., Shin, V. Y., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.014 · Cited by 91
Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells
Yang, X., Wang, J., Zhou, Y., Wang, Y., Wang, S., & Zhang, W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.030 · Cited by 88
Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers
Gibert, B., Hadchity, É., Czekalla, A., Aloy, M.-T., Colas, P., Rodriguez‐Lafrasse, C., Arrigo, A., & Diaz‐Latoud, C. (2011) · Oncogene · doi:10.1038/onc.2011.73 · Cited by 87
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 87
Landriscina, M., Amoroso, M. R., Piscazzi, A., & Esposito, F. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.078 · Cited by 87
Guo, J., Li, X., Zhang, W., Chen, Y., Zhu, S., Chen, L., Xu, R., Lv, Y., Wu, D., Guo, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48992-7 · Cited by 85
Immune Mechanism of the Antitumor Effects Generated by Bortezomib
Chang, C.-L., Hsu, Y.-T., Wu, C.-C., Yang, Y., Wang, C., Wu, T.-Q., & Hung, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103826 · Cited by 84
Mesenchymal Stem Cells Modulate Albumin-Induced Renal Tubular Inflammation and Fibrosis
Wu, H., Yiu, W. H., Li, R. X., Wong, D. W. L., Leung, J. C. K., Chan, L. Y. Y., Zhang, Y., Lian, Q., Lin, M. Y., Tse, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090883 · Cited by 80
Multifaceted roles of HSF1 in cancer
Jiang, S., Tu, K., Fu, Q., Schmitt, D. C., Zhou, L., Lu, N., & Zhao, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3674-x · Cited by 79
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
Makhlough, A., Shekarchian, S., Moghadasali, R., Einollahi, B., Hosseini, S. E., Jaroughi, N., Bolurieh, T., Baharvand, H., & Aghdami, N. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0557-7 · Cited by 77
Robinson, D. C., Jaresko, G. S., & Baker, D. E. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_27 · Cited by 76
Subcellular Hsp70 Inhibitors Promote Cancer Cell Death via Different Mechanisms
Park, S.-H., Baek, K., Shin, I., & Shin, I. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.06.010 · Cited by 76
Tang, H., Chen, Y., Liu, X., Wang, S., Lv, Y., Wu, D., Wang, Q., Luo, M., & Deng, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9615 · Cited by 75
Vilaboa, N. E., Boré, A., Martin-Saavedra, F., Bayford, M., Winfield, N., Firth‐Clark, S., Kirton, S. B., & Voellmy, R. W. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx194 · Cited by 72
Mitochondrial Chaperonin HSP60 Is the Apoptosis-Related Target for Myrtucommulone
Wiechmann, K., Müller, H., König, S., Wielsch, N., Svatoš, A., Jauch, J., & Werz, O. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.04.008 · Cited by 71
Han, Y., Kim, S. M., Lee, J. H., Jung, S. K., Noh, H., & Lee, S. H. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12535 · Cited by 70
Self-citationShevtsov, M. A., Pitkin, E., Ischenko, A. M., Stangl, S., Khachatryan, W. А., Galibin, O. V., Edmond, S., Lobinger, D., & Multhoff, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00454 · Cited by 70
Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells
Chen, X., Dong, X., Gao, H., Jiang, Y., Jin, Y., Chang, Y., Chen, L., & Wang, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4600 · Cited by 69
Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma
Meng, J., Liu, Y., Han, J., Tan, Q., Chen, S., Qiao, K., Zhou, H., Sun, T., & Yang, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0640-9 · Cited by 69
Heat shock protein DNAJB 8 is a novel target for immunotherapy of colon cancer‐initiating cells
Morita, R., Nishizawa, S., Torigoe, T., Takahashi, A., Tamura, Y., Tsukahara, T., Kanaseki, T., Sokolovskaya, A., Kochin, V., Kondo, T., et al. (2014) · Cancer Science · doi:10.1111/cas.12362 · Cited by 68
Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer
Nagaraju, G. P., Zakka, K. M., Landry, J. C., Shaib, W. L., Lesinski, G. B., & El‐Rayes, B. F. (2019) · International Journal of Cancer · doi:10.1002/ijc.32227 · Cited by 68
KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis
Yang, S., Ren, X., Liang, Y., YongRong, Y., Zhou, Y., Hu, J., Wang, Z., Song, F., Wang, F., Liao, W., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0978-0 · Cited by 68
Ahn, J.-Y., Lee, J., Min, H., & Lee, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5327 · Cited by 65
Radioresistance is associated to increased Hsp70 content in human glioblastoma cell lines
da Rocha, A. B., Regner, A., Grivicich, I., Schunemann, D. P., Diel, C. L., Kovaleski, G., de Farias, C. B., Mondadori, E., Almeida, L., Filho, A. B., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.3.777 · Cited by 65
Role of membrane Hsp70 in radiation sensitivity of tumor cells
Murakami, N., Kühnel, A., Schmid, T. E., Ilicic, K., Stangl, S., Braun, I. S., Gehrmann, M., Molls, M., Itami, J., & Multhoff, G. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0461-1 · Cited by 62
Górska‐Ponikowska, M., Marino, A., Zmijewski, M. A., Campanella, C., Cappello, F., Wasiewicz, T., Kuban‐Jankowska, A., Daca, A., Sielicka, A., Popowska, U., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071135 · Cited by 62
Rao, A., Taylor, J. L., Chi-Sabins, N., Kawabe, M., Gooding, W. E., & Storkus, W. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0538 · Cited by 62
Epigenetic inactivation ofMCJ (DNAJD1) in malignant paediatric brain tumours
Lindsey, J. C., Lusher, M. E., Strathdee, G. R., Brown, R. E., Gilbertson, R. J., Bailey, S., Ellison, D. W., & Clifford, S. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21353 · Cited by 61
Ishibashi, J., Yamashita, K., Ishikawa, T., Hosokawa, H., Sumida, K., Nagayama, M., & Kitamura, S. (2007) · Medical Oncology · doi:10.1007/s12032-007-9020-4 · Cited by 61
Wong, S. C. C., Wong, V. H., Chan, C. M. L., Ma, B. B. Y., Hui, E. P., Wong, M. C. K., Lam, M. Y. Y., Au, T. C. C., Chan, W.-H., Cheuk, W., et al. (2008) · Oncology Reports · doi:10.3892/or.20.1.89 · Cited by 61
Lee, K., Lee, J., Han, S., Im, S., Kim, T., Oh, D., & Bang, Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01944.x · Cited by 60
Zhang, N., Wu, Y., Lyu, X., Li, B., Yan, X., Xiong, H., Li, X., Huang, G., Zeng, Y., Zhang, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.039 · Cited by 59
Heat shock proteins and cancer: How can nanomedicine be harnessed?
Sauvage, F., Messaoudi, S., Fattal, E., BARRATT, G. M., & Vergnaud, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.013 · Cited by 57
Proteomic investigation of anti‐tumor activities exerted by sinularin against A 2058 melanoma cells
Su, T., Lin, J., Chiu, C., Chen, J. Y., Su, J., Cheng, Z., Hwang, W., Huang, H. H., & Wu, Y. (2012) · Electrophoresis · doi:10.1002/elps.201100462 · Cited by 56
Sensitizing tumor cells to radiation by targeting the heat shock response
Schilling, D., Kühnel, A., Konrad, S., Tetzlaff, F., Bayer, C., Yaglom, J. A., & Multhoff, G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.033 · Cited by 55
Shevtsov, M. A., Pozdnyakov, A. V., Михрина, А. Л., Yakovleva, L. Y., Nikolaev, B. P., Добродумов, А. В., Komarova, E. Y., Мешалкина, Д. А., Ischenko, A. M., Pitkin, E., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28858 · Cited by 52
Xu, J., Shi, Q., Xu, W., Zhou, Q., Shi, R., Ma, Y., Chen, D., Zhu, L., Feng, L., Cheng, A. S. L., et al. (2019) · Theranostics · doi:10.7150/thno.31301 · Cited by 52
Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer
Vahid, S., Thaper, D., Gibson, K. F., Bishop, J. L., & Zoubeidi, A. (2016) · Scientific Reports · doi:10.1038/srep31842 · Cited by 51
Cho, T.-M., Kim, J. Y., Kim, Y. J., Sung, D., Oh, E., Jang, S., Farrand, L., Hoang, V.-H., Nguyen, C.-T., Ann, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.029 · Cited by 51
Kim, R. H., Kim, R., Chen, W., Hu, S., Shin, K.-H., Park, N.-H., & Kang, M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn225 · Cited by 50
Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation
Hu, F., Yu, C., Hsieh, P., Liao, Y., Lu, M., & Chu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21338 · Cited by 50
Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function
Gibert, B., Simon, S., Dimitrova, V., Diaz‐Latoud, C., & Arrigo, A. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0075 · Cited by 48
Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis
Lee, J. H., Han, Y.-S., Yoon, Y. M., Yun, C. W., Yun, S. P., Kim, S. M., Kwon, H. Y., Jeong, D., Baek, M. J., Lee, H., et al. (2017) · Oncogene · doi:10.1038/onc.2017.263 · Cited by 46
Self-citationLee, J. H., Yun, C., Hur, J., & Lee, S. H. (2018) · Marine Drugs · doi:10.3390/md16040121 · Cited by 46
Self-citationYang, L., Li, H., Jiang, Y., Zuo, J., & Liu, W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.004 · Cited by 45
Li, J., Tang, C., Li, L., Li, R., & Fan, Y. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0331-1 · Cited by 44
Lee, J. H., Yun, C. W., & Lee, S. H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.033 · Cited by 44
Self-citationStem cell extracellular vesicles and kidney injury
Grange, C., Iampietro, C., & Bussolati, B. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.11.02 · Cited by 44
Jin, H., Hong, S., Kim, J., Kim, M., Chang, Y. H., Hong, Y. J., Lee, J., & Park, I. (2019) · Oncology Reports · doi:10.3892/or.2019.7036 · Cited by 44
Li, J., Tang, C., Li, L., Li, R., & Fan, Y. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2149-2 · Cited by 43
Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells
Le, H. T., Nguyen, H. T., Min, H., Hyun, S. Y., Kwon, S., Lee, Y., Le, T. H. V., Lee, J., Park, J. H., & Lee, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.013 · Cited by 43
Wei, Q., White, M. C., Choi, W., Guo, C. C., Dinney, C. P., McConkey, D. J., & Siefker-Radtke, A. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069509 · Cited by 41
Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK – ERK pathway
Hu, Y., Yang, L., Yang, Y., Han, Y., Wang, Y., Liu, W., & Zuo, J. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12905 · Cited by 40
Mumin, N. H., Drobnitzky, N., Patel, A., Lourenço, L. M., Cahill, F. F., Jiang, Y., Kong, A. H., & Ryan, A. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5295-z · Cited by 40
Ray-Coquard, I. L., Braicu, E. I., Berger, R., Mahner, S., Sehouli, J., Pujade-Lauraine, É., Cassier, P. A., Moll, U. M., Ulmer, H., Leunen, K., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00832 · Cited by 40
DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling
Park, S., Choi, H.-K., Seo, J. S., Yoo, J., Jeong, J., Choi, Y., Choi, K., & Yoon, H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.07.024 · Cited by 39
Tian, H., Lü, Y., Shah, S. P., Wang, Q., & Hong, S. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0220 · Cited by 39
Fu, W.-M., Zhang, J.-F., Wang, H., Xi, Z., Wang, W.-M., Zhuang, P., Zhu, X. M., Chen, S., Chan, T.-M., Leung, K., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.032 · Cited by 39
Lee, J.-H., Sun, D., Cho, K.-J., Kim, M., Hong, M.-H., Kim, I., Lee, J. H., & Lee, J. H. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0143-3 · Cited by 39
Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells.
Zhang, Z., Xie, Z., Sun, G., Yang, P., Li, J., Yang, H., Xiao, S., Liu, Y., Qiu, H., Qin, L., et al. (2015) · Europe PMC (PubMed Central) · Cited by 39
McLaughlin, M., Barker, H. E., Khan, A., Pedersen, M., Dillon, M. T., Mansfield, D., Patel, R., Kyula, J., Bhide, S. A., Newbold, K. L., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3084-0 · Cited by 39
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
Lin, S., Lin, J., Hsueh, C., Chou, T., Yeh, C., Chen, M., & Wong, R. J. (2017) · Oncotarget · doi:10.18632/oncotarget.17180 · Cited by 39
Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma
Xu, M., Jin, T., Chen, L., Zhang, X., Zhu, G., Wang, Q., & Lin, Z. (2019) · Gene · doi:10.1016/j.gene.2019.02.033 · Cited by 38
Hsia, T., Lin, J.-H., Hsu, S., Tang, N.-Y., Lu, H.-F., Wu, S., Lin, J., & Chung, J. (2014) · Environmental Toxicology · doi:10.1002/tox.21986 · Cited by 35
UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells
Sane, S., Hafner, A., Srinivasan, R., Masood, D., Slunecka, J. L., Noldner, C. J., Hanson, A., Kruisselbrink, T., Wang, X., Wang, Y., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12372 · Cited by 35
Patel, K. R., Wen, J., Magliocca, K. R., Müller, S., Liu, Y., Chen, Z. G., Saba, N. F., & Diaz, R. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2584-8 · Cited by 34
Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ
Cassel, J. A., Ilyin, S., McDonnell, M. E., & Reitz, A. B. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.067 · Cited by 34
Merchant, S., & Korbelik, M. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0227-5 · Cited by 34
Abu-hadid, M. M., Wilkes, J. D., El-Akawi, Z. J., Pendyala, L., & Perez, R. P. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00255-3 · Cited by 33
Schweiger, T., Nikolowsky, C., Starlinger, P. P., Traxler, D., Zimmermann, M., Birner, P., Hegedűs, B., Döme, B., Bergmann, M. M., Mildner, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120724 · Cited by 33
Lee, H. H., Saini, N., Parris, A. B., Zhao, M., & Yang, X. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4073 · Cited by 33
Yamashita, M., Hirohashi, Y., Torigoe, T., Kusumoto, H., Murai, A., Imagawa, T., & Sato, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146501 · Cited by 32
Takashima, K., Oshiumi, H., Matsumoto, M., & Seya, T. (2017) · Journal of Innate Immunity · doi:10.1159/000480740 · Cited by 32
Yang, H., Lee, M.-H., Park, I., Jeon, H., Choi, J., Seo, S., Kim, S., Koh, G. Y., Park, K., & Lee, D. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.040 · Cited by 31
Cao, X., Zhou, Y., Sun, H., Xu, M., Bi, X., Zhao, Z., Shen, B., Wan, F., Hong, Z., Lan, L., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.004 · Cited by 31
Overexpression of Hsc70 promotes proliferation, migration, and invasion of human glioma cells
Sun, G., Cao, Y., Xu, Y., Huai, D., Chen, P., Guo, J. X., Li, M., & Dai, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28362 · Cited by 31
Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes
Altun, B., Yılmaz, R., Aki, F. T., Akoğlu, H., Zeybek, N. D., Pişkinpaşa, S., Uçkan, D., Puralı, N., Korkusuz, P., & Turgan, Ç. (2012) · American Journal of Nephrology · doi:10.1159/000339167 · Cited by 30
Haggerty, T. J., Dunn, I. S., Rose, L. B., Newton, E. E., Pandolfi, F., & Kurnick, J. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114506 · Cited by 30
Major heat shock protein Hsp72 controls oncogene‐induced senescence
Sherman, M. Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05196.x · Cited by 29
Zhou, Y., Ma, J., Zhang, J., He, L., Gong, J., & Long, C. (2016) · Oncology Reports · doi:10.3892/or.2016.5286 · Cited by 29
Mortalin expression in pancreatic cancer and its clinical and prognostic significance
Cui, X., Li, Z., Piao, J., Li, J., Li, L., Lin, Z., & Jin, A. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.03.015 · Cited by 29
Huang, C., Wei, P., Chen, W., Chang, W., & Chang, Y. (2018) · Cells · doi:10.3390/cells7120262 · Cited by 27
吉冨, 恵., Murakami, A., Yakabe, K., 末岡, 幸., 縄田, 修., & Sugino, N. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12325 · Cited by 26
Ritchie, J. P., Green, D., Alderson, H. V., Chiu, D. Y. Y., Sinha, S., & Kalra, P. A. (2015) · Nephrology · doi:10.1111/nep.12501 · Cited by 26
Kinzel, L., Ernst, A., Orth, M., Albrecht, V. S., Hennel, R., Brix, N., Frey, B., Gaipl, U. S., Zuchtriegel, G., Reichel, C. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9774 · Cited by 26
Lee, Y., Sunada, S., Hirakawa, H., Fujimori, A., Nickoloff, J. A., & Okayasu, R. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0573 · Cited by 26
Canonici, A., Qadir, Z., Conlon, N. T., Collins, D. M., O’Brien, N. A., Walsh, N., Eustace, A. J., O’Donovan, N., & Crown, J. P. (2018) · Investigational New Drugs · doi:10.1007/s10637-017-0556-7 · Cited by 26
Park, K., Hong, Y. S., Choi, J., Yoon, S., Kang, J., Kim, D., Lee, K. P., Im, H.-S., Lee, C. H., Seo, S., et al. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.12.259 · Cited by 26
Guo, A., Lü, P., Lee, J. C., Zhen, C., Chiosis, G., & Wang, Y. L. (2017) · Oncogene · doi:10.1038/onc.2016.494 · Cited by 25
Gráf, L., Barabás, L., Madaras, B., Garam, N., Maláti, É., Horváth, L., Prohászka, Z., Horváth, Z., & Kocsis, J. (2018) · Cancer Biomarkers · doi:10.3233/cbm-181683 · Cited by 25
Dai, W., Ye, J., Zhang, Z., Yang, L., Ren, H. J., Wu, H., Chen, J., Ma, J., Zhai, E., Cai, S., et al. (2018) · Diagnostic Pathology · doi:10.1186/s13000-018-0755-3 · Cited by 23
Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer
Luo, C., Fan, W. H., Jiang, Y., Zhou, S., & Cheng, W. (2018) · Medical Science Monitor · doi:10.12659/msm.906413 · Cited by 22
HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
Lu, H., Sun, C., Zhou, T., Zhou, B., Guo, E., Shan, W., Xia, M., Li, K., Weng, D., Li, M., et al. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14496932933656 · Cited by 20
Liu, J., Sun, W., Dong, W., Wang, Z., Qin, Y. H., Zhang, T., & Zhang, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.056 · Cited by 20
Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target
Mu, Y., Rogers, L. J., Suchowerska, N., Choe, D. J., Al‐Dabbas, M. A., Narula, R. S., Lyons, J. G., Sved, P. D., Zhong, L., & Dong, Q. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.05.021 · Cited by 20
The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail
Zhang, S., Zhang, X., Huang, S., Chen, M., Shen, S., Ding, X., Lv, Y., & Zou, X. (2015) · Pancreas · doi:10.1097/mpa.0000000000000418 · Cited by 18
Liu, T., Singh, R., Rios, Z., Bhushan, A., Li, M., Sheridan, P. P., Bearden, S. E., Lai, J. C. K., Agbenowu, S., Cao, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.036 · Cited by 17
TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression
Clemons, N. J., & Anderson, R. L. (2006) · Cell Stress and Chaperones · doi:10.1379/csc-206.1 · Cited by 16
Takahashi, K., Tanaka, M., Yashiro, M., Matsumoto, M., Ohtsuka, A., Nakayama, K. I., Izumi, Y., Nagayama, K., Miura, K., Iwao, H., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.002 · Cited by 15
Bai, J., Zhou, G., Qiu, Y., Hu, Y., Liu, J., Zhao, J., Zhang, S., & Zhang, J. (2017) · Cancer Science · doi:10.1111/cas.13238 · Cited by 13
Huang, Z., Yang, C., Sun, S., Nan, Y., Lang, Z., Wang, X., Zhao, J., & Liu, Y. (2017) · Pharmacology · doi:10.1159/000479320 · Cited by 13
Kurihara, E., Shien, K., Torigoe, H., Takeda, T., Takahashi, Y., Ogoshi, Y., Yoshioka, T., Namba, K., Sato, H., Suzawa, K., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13283 · Cited by 12
Lee, Y.-J., Park, K.-S., Heo, S., Nam, H.-S., Cho, M. K., & Lee, S.-H. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01181-6 · Cited by 10
Self-citationZhang, Y., Zhang, Y., Chen, J., Liu, Y., & Luo, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126075 · Cited by 9
Cited by
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022) · MedComm · doi:10.1002/mco2.161 · Cited by 779
Small molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting
Parma, B., Ramesh, V., Gollavilli, P. N., Siddiqui, A., Pinna, L., Schwab, A., Marschall, S., Zhang, S., Pilarsky, C., Napoli, F., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02049-8 · Cited by 46
Metadata
- Authors
- Yun, C. W., Kim, H. J., Lim, J. H., & Lee, S. H.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-12-24
- Volume
- 9
- Issue
- 1
- Pages
- 60
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2997805606
- Cited by
- 284
- References
- 177
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.